| Bioactivity | RIPK1-IN-13 (compound 28) is a selective inhibitor for receptor-interacting serine/threonine-protein kinase 1 (RIPK1), which exhibits inhibitory effect in human leukaemia cells U937[1]. |
| Formula | C22H22N4O3S |
| Molar Mass | 422.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Petró JL, et al., Design, synthesis and biological evaluation of novel cyclic malonamide derivatives as selective RIPK1 inhibitors. Bioorg Med Chem Lett. 2024 Mar 1;100:129643. |